Cite
HARVARD Citation
Shibata, N. et al. (2022). Development of a degrader against oncogenic fusion protein FGFR3-TACC3. Bioorganic & medicinal chemistry letters. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shibata, N. et al. (2022). Development of a degrader against oncogenic fusion protein FGFR3-TACC3. Bioorganic & medicinal chemistry letters. p. . [Online].